Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibodies as defensive enzymes.

Sudhir Paul1, Yasuhiro Nishiyama, Stephanie Planque

  • 1Chemical Immunology and Therapeutics Research Center, Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, MSB 2.250, 6431 Fannin, Houston, TX 77030, USA. Sudhir.Paul@uth.tmc.edu

Springer Seminars in Immunopathology
|January 6, 2005
PubMed
Summary

Proteolytic antibodies, found in healthy humans, can cleave harmful proteins like HIV-1 gp120 and amyloid beta-peptide. These beneficial antibodies may play roles in defending against viruses and neurodegenerative diseases like Alzheimer's.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Sinus Rhythm: Rhythm Control and Mechanism-Based Secondary Prevention in Atrial Fibrillation-Related Stroke.

Journal of atherosclerosis and thrombosis·2026
Same author

Aluminium ammonium sulphate induces epithelial pyroptosis and eosinophilic inflammation under dysbiotic conditions: ameliorative effects of heparin.

Cell death discovery·2026
Same author

Homocysteine increases phosphorylation and aggregation of α-synuclein.

Journal of clinical biochemistry and nutrition·2026
Same author

Vascular Ehlers-Danlos Syndrome Diagnosed after Cerebral Infarction with a Subarachnoid Hemorrhage.

Internal medicine (Tokyo, Japan)·2026
Same author

Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation: The STABLED Randomized Clinical Trial.

JAMA neurology·2026
Same author

Asymptomatic Intracranial Hemorrhage Is Associated With Poor Outcomes After Mechanical Thrombectomy for Large Vessel Occlusion.

Stroke (Hoboken, N.J.)·2026

Area of Science:

  • Immunology
  • Biochemistry
  • Molecular Biology

Background:

  • Antibodies (Abs) and enzymes share structural and functional similarities.
  • Healthy humans possess antibodies with promiscuous peptidase activity, originating from germline immunoglobulin genes.
  • These antibodies feature a serine protease-like nucleophilic function capable of interacting with antigens.

Purpose of the Study:

  • To explore the dual role of proteolytic antibodies in both pathogenic and beneficial functions.
  • To highlight recent findings on the beneficial roles of antibody-catalyzed reactions.
  • To investigate the potential of proteolytic antibodies in combating viral infections and neurodegenerative diseases.

Main Methods:

  • Analysis of antibody structure and function, focusing on germline variable domain immunoglobulin genes.

Related Experiment Videos

  • Investigation of antibody-antigen interactions, particularly covalent binding to nucleophilic sites.
  • Case studies examining the cleavage of specific proteins (HIV-1 gp120, amyloid beta-peptide) by human antibodies (IgM, IgG).
  • Main Results:

    • Antibodies with peptidase activity are common in healthy individuals.
    • Immunization with electrophilic antigens can induce proteolytic antibodies.
    • Proteolytic antibodies demonstrate beneficial functions, including selective cleavage of HIV-1 gp120 and amyloid beta-peptide.

    Conclusions:

    • Proteolytic antibodies can serve beneficial roles beyond previously recognized pathogenic associations.
    • Antibody-mediated cleavage of HIV-1 gp120 suggests a defense mechanism against viral entry.
    • Cleavage of amyloid beta-peptide by antibodies indicates a potential endogenous response to Alzheimer's disease pathogenesis.